Biotech Stocks Plummet After Bone Disease Treatment Failures
Ultragenyx and Mereo's late-stage clinical trial for a rare bone disease drug has failed, marking a significant setback for the development program.
All articles tagged with #late stage
Ultragenyx and Mereo's late-stage clinical trial for a rare bone disease drug has failed, marking a significant setback for the development program.

A new study published in the journal JAMA Oncology reveals that 59% of women in India are diagnosed with breast cancer after it has already spread outside the breast to nearby structures or lymph nodes, while 11% are diagnosed with cancer that has spread to distant parts of the body. The study, which analyzed data from over 20 lakh women across 81 countries, highlights the need for early detection and timely diagnosis to improve survival outcomes. The findings also show that advanced stage breast cancer is more prevalent in older age groups of women.